Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
Clinical trial NCT02099110 · COMPLETED
Trial details
- NCT number
- NCT02099110
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-22
- Primary completion
- 2016-05-26
- Enrollment
- 1233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.